CureVac (CVAC) Stock Highlights

2.87 | -4.01%

2024-12-21 05:09:47

CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-generation COVID-19 vaccine. CureVacs first attempt to develop a COVID-19 vaccine did not have sufficient efficacy data, and its trials were discontinued in October 2021. The companys other pipeline candidates include mRNA vaccines for influenza, rabies, and malaria. Additionally, CureVac is in the early stages of development for oncology and molecular therapies spanning tumors, liver, ocular, and lung diseases.

Statistics

Range Today

2.83 3.02

Volume Today 820.6K

Range 1 Year

2.21 5.28

Volume 1 Year 215.22M

Range 3 Year

2.21 41.09

Volume 3 Year 546.07M

Range 10 Year

2.21 151.8

Volume 10 Year 895.31M

Highlights

Market Capitalization 637.05M (small)

Floating Shares 123.54M

Current Price 2.87

Price To Earnings -2.1

Price To Revenue 7.19

Price To Book 1.69

Earnings Per Share -1.34

Payout Ratio 0%

Performance

Latest -4.01%

1 Month +13.44%

3 Months -13.29%

6 Months -15.09%

1 Year -32.63%

3 Years -92.93%

5 Years -93.55%

10 Years -93.55%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.